Fecal carriage of extended spectrum beta-lactamase producing Enterobacteriaceae among HIV infected children at the University of Gondar Comprehensive Specialized Hospital Gondar, Ethiopia.

Abstract

BACKGROUND:

Human immunodeficiency virus (HIV) and extended spectrum beta lactamase (ESBL) producing Enterobacteriaceae infections are the major challenges in sub-Saharan Africa. Data on the carriage rate of ESBL producing Enterobacteriaceae among HIV infected children is lacking in Ethiopia. Hence this study was aimed to investigate fecal carriage of ESBL producing Enterobacteriaceae among HIV infected children at the University of Gondar comprehensive Specialized Hospital.

METHODS:

A cross-sectional study was conducted among HIV infected children from January to April 2020. Stool specimens were collected from 161 study participants by convenient sampling and cultured on MacConkey agar. Biochemical identification, antimicrobial susceptibility testing including ESBL production were carried out. Data were analyzed by SPSS version-20 and P-value < 0.05 on multivariate logistic regression analysis was regarded as statistically significant.

RESULTS:

From a total of 161 study participants male to female ratio was 1:1.1. Moreover; 96.3% of participants were in HIV stage-I and 90.1% had at least a year highly active antiretroviral therapy exposure. A total of 186 Enterobacteriaceae, with E. coli 60% and K. pneumonia 16.13% predominance were isolated from 161 participants. Majority of isolates were most resistant to amoxicillin (95.1%) and sensitive to CHL (94.1%), CXT (91.4%) and CAZ (91.4%). There were 71(38.17%) multidrug resistant isolates, 13 of which were also ESBL producers. The overall ESBL carriage rate was 32/161 (19.9%). History of antibiotic use was the independent factor associated with ESBL carriage (AOR 3.23 (95% CI 1.054-9.88)) and P-value of 0.04.

CONCLUSION:

ESBL carriage rate of HIV infected children was considerable. Previous antibiotic use was the independent factor. Regular screening for antibiotic resistance on HIV patients before prescription and large-scale antibiotic resistance survey including healthy community may be important.

• Authors: Biruk Bayleyegn, Roman Fisaha, Desie Kasew
• Journal: AIDS research and therapy (AIDS Res Ther) Vol. 18 Issue 1 Pg. 19 (04 21 2021) ISSN: 1742-6405 [Electronic] England
• PMID: 33882946 (Publication Type: Journal Article)

Chemical References

• beta-Lactamases

Topics

• Child
• Cross-Sectional Studies
• Enterobacteriaceae
• Enterobacteriaceae Infections (drug therapy, epidemiology)
• Escherichia coli
• Ethiopia (epidemiology)
• Female
• HIV Infections (drug therapy, epidemiology)
• Hospitals
• Humans
• Male
• beta-Lactamases